GleanMark

ENFORCER Trademark

ENFORCER is a USPTO trademark filed by INCYTE HOLDINGS CORPORATION. Status: Registered.

Trademark Facts

MarkENFORCER
Serial Number88461039
Registration Number5981450
StatusRegistered
Filing Date2019-06-05
Registration Date2020-02-11
Mark TypeWord
Nice Classes005 (Pharmaceuticals), 042 (Software & IT)
OwnerINCYTE HOLDINGS CORPORATION
Attorney of RecordFrances M. Jagla
Prosecution Events28
Latest EventREM1 on 2025-02-11

Goods & Services

Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; providing medical and scientific research information in the field of pharmaceuticals; Research and development services in the field of antibodies

Related